Literature DB >> 28361736

DNA Replication in Mycobacterium tuberculosis.

Zanele Ditse1, Meindert H Lamers2, Digby F Warner3,4.   

Abstract

Faithful replication and maintenance of the genome are essential to the ability of any organism to survive and propagate. For an obligate pathogen such as Mycobacterium tuberculosis that has to complete successive cycles of transmission, infection, and disease in order to retain a foothold in the human population, this requires that genome replication and maintenance must be accomplished under the metabolic, immune, and antibiotic stresses encountered during passage through variable host environments. Comparative genomic analyses have established that chromosomal mutations enable M. tuberculosis to adapt to these stresses: the emergence of drug-resistant isolates provides direct evidence of this capacity, so too the well-documented genetic diversity among M. tuberculosis lineages across geographic loci, as well as the microvariation within individual patients that is increasingly observed as whole-genome sequencing methodologies are applied to clinical samples and tuberculosis (TB) disease models. However, the precise mutagenic mechanisms responsible for M. tuberculosis evolution and adaptation are poorly understood. Here, we summarize current knowledge of the machinery responsible for DNA replication in M. tuberculosis, and discuss the potential contribution of the expanded complement of mycobacterial DNA polymerases to mutagenesis. We also consider briefly the possible role of DNA replication-in particular, its regulation and coordination with cell division-in the ability of M. tuberculosis to withstand antibacterial stresses, including host immune effectors and antibiotics, through the generation at the population level of a tolerant state, or through the formation of a subpopulation of persister bacilli-both of which might be relevant to the emergence and fixation of genetic drug resistance.

Entities:  

Mesh:

Year:  2017        PMID: 28361736      PMCID: PMC5507077          DOI: 10.1128/microbiolspec.TBTB2-0027-2016

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  196 in total

Review 1.  DNA replicases from a bacterial perspective.

Authors:  Charles S McHenry
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

2.  A direct proofreader-clamp interaction stabilizes the Pol III replicase in the polymerization mode.

Authors:  Slobodan Jergic; Nicholas P Horan; Mohamed M Elshenawy; Claire E Mason; Thitima Urathamakul; Kiyoshi Ozawa; Andrew Robinson; Joris M H Goudsmits; Yao Wang; Xuefeng Pan; Jennifer L Beck; Antoine M van Oijen; Thomas Huber; Samir M Hamdan; Nicholas E Dixon
Journal:  EMBO J       Date:  2013-02-22       Impact factor: 11.598

3.  Physical and functional interactions between 3-methyladenine DNA glycosylase and topoisomerase I in mycobacteria.

Authors:  Qiong Yang; Feng Huang; Lihua Hu; Zheng-Guo He
Journal:  Biochemistry (Mosc)       Date:  2012-04       Impact factor: 2.487

4.  Verapamil increases the bactericidal activity of bedaquiline against Mycobacterium tuberculosis in a mouse model.

Authors:  Shashank Gupta; Sandeep Tyagi; William R Bishai
Journal:  Antimicrob Agents Chemother       Date:  2014-10-20       Impact factor: 5.191

5.  The structure of T. aquaticus DNA polymerase III is distinct from eukaryotic replicative DNA polymerases.

Authors:  Scott Bailey; Richard A Wing; Thomas A Steitz
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

6.  ClpR protein-like regulator specifically recognizes RecA protein-independent promoter motif and broadly regulates expression of DNA damage-inducible genes in mycobacteria.

Authors:  Yi Wang; Yuanxia Huang; Chaolun Xue; Yang He; Zheng-Guo He
Journal:  J Biol Chem       Date:  2011-07-19       Impact factor: 5.157

7.  DNA repair in Mycobacterium tuberculosis. What have we learnt from the genome sequence?

Authors:  V Mizrahi; S J Andersen
Journal:  Mol Microbiol       Date:  1998-09       Impact factor: 3.501

8.  Function and regulation of class I ribonucleotide reductase-encoding genes in mycobacteria.

Authors:  Mohube B Mowa; Digby F Warner; Gilla Kaplan; Bavesh D Kana; Valerie Mizrahi
Journal:  J Bacteriol       Date:  2008-11-21       Impact factor: 3.490

9.  Choreography of the Mycobacterium replication machinery during the cell cycle.

Authors:  Damian Trojanowski; Katarzyna Ginda; Monika Pióro; Joanna Hołówka; Partycja Skut; Dagmara Jakimowicz; Jolanta Zakrzewska-Czerwińska
Journal:  MBio       Date:  2015-02-17       Impact factor: 7.867

10.  Evolution and diversity of clonal bacteria: the paradigm of Mycobacterium tuberculosis.

Authors:  Tiago Dos Vultos; Olga Mestre; Jean Rauzier; Marcin Golec; Nalin Rastogi; Voahangy Rasolofo; Tone Tonjum; Christophe Sola; Ivan Matic; Brigitte Gicquel
Journal:  PLoS One       Date:  2008-02-06       Impact factor: 3.240

View more
  11 in total

1.  The Error-Prone Polymerase DnaE2 Mediates the Evolution of Antibiotic Resistance in Persister Mycobacterial Cells.

Authors:  S Salini; Sinchana G Bhat; Saba Naz; Ramanathan Natesh; R Ajay Kumar; Vinay Kumar Nandicoori; Krishna Kurthkoti
Journal:  Antimicrob Agents Chemother       Date:  2022-03-15       Impact factor: 5.938

Review 2.  Targeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis.

Authors:  Michael A Reiche; Digby F Warner; Valerie Mizrahi
Journal:  Front Mol Biosci       Date:  2017-11-14

3.  Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.

Authors:  Timothy J de Wet; Digby F Warner; Valerie Mizrahi
Journal:  Acc Chem Res       Date:  2019-07-30       Impact factor: 22.384

4.  Mycobacterial DNA polymerase I: activities and crystal structures of the POL domain as apoenzyme and in complex with a DNA primer-template and of the full-length FEN/EXO-POL enzyme.

Authors:  Shreya Ghosh; Yehuda Goldgur; Stewart Shuman
Journal:  Nucleic Acids Res       Date:  2020-04-06       Impact factor: 16.971

Review 5.  Understanding Metabolic Regulation Between Host and Pathogens: New Opportunities for the Development of Improved Therapeutic Strategies Against Mycobacterium tuberculosis Infection.

Authors:  Ji-Hae Park; Dahee Shim; Keu Eun San Kim; Wonsik Lee; Sung Jae Shin
Journal:  Front Cell Infect Microbiol       Date:  2021-03-16       Impact factor: 5.293

6.  Flow cytometry method for absolute counting and single-cell phenotyping of mycobacteria.

Authors:  David A Barr; Charles Omollo; Mandy Mason; Anastasia Koch; Robert J Wilkinson; David G Lalloo; Graeme Meintjes; Valerie Mizrahi; Digby F Warner; Gerry Davies
Journal:  Sci Rep       Date:  2021-09-20       Impact factor: 4.379

7.  DNA-Dependent Binding of Nargenicin to DnaE1 Inhibits Replication in Mycobacterium tuberculosis.

Authors:  Melissa D Chengalroyen; Mandy K Mason; Alessandro Borsellini; Raffaella Tassoni; Garth L Abrahams; Sasha Lynch; Yong-Mo Ahn; Jon Ambler; Katherine Young; Brendan M Crowley; David B Olsen; Digby F Warner; Clifton E Barry Iii; Helena I M Boshoff; Meindert H Lamers; Valerie Mizrahi
Journal:  ACS Infect Dis       Date:  2022-02-10       Impact factor: 5.084

Review 8.  Stable Regulation of Cell Cycle Events in Mycobacteria: Insights From Inherently Heterogeneous Bacterial Populations.

Authors:  Michelle M Logsdon; Bree B Aldridge
Journal:  Front Microbiol       Date:  2018-03-21       Impact factor: 5.640

Review 9.  DnaG Primase-A Target for the Development of Novel Antibacterial Agents.

Authors:  Stefan Ilic; Shira Cohen; Meenakshi Singh; Benjamin Tam; Adi Dayan; Barak Akabayov
Journal:  Antibiotics (Basel)       Date:  2018-08-13

10.  Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice.

Authors:  Wassihun Wedajo Aragaw; Christine Roubert; Evelyne Fontaine; Sophie Lagrange; Matthew D Zimmerman; Véronique Dartois; Martin Gengenbacher; Thomas Dick
Journal:  Antimicrob Agents Chemother       Date:  2021-11-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.